Model DIU for Cataract

Phase-Based Progress Estimates
Coastal Vision, Orange, CA
Model DIU - Device
All Sexes
What conditions do you have?

Study Summary

This is a prospective, multi-center, masked, three-arm, randomized clinical study of the TECNIS Eyhance Toric II IOL (test #1) and TECNIS Synergy Toric II (test #2) compared to the TECNIS Toric 1-Piece IOL (control).

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6-months post-operative

6-months post-operative
Rotational Stability of IOL

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

TECNIS Toric 1-Piece IOL
1 of 3
TECNIS Synergy Toric II
1 of 3
Eyhance Toric II IOL
1 of 3
Active Control
Experimental Treatment

375 Total Participants · 3 Treatment Groups

Primary Treatment: Model DIU · No Placebo Group · N/A

TECNIS Synergy Toric II
Experimental Group · 1 Intervention: Model DFW · Intervention Types: Device
Eyhance Toric II IOL
Experimental Group · 1 Intervention: Model DIU · Intervention Types: Device
TECNIS Toric 1-Piece IOL
ActiveComparator Group · 1 Intervention: Model ZCT · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6-months post-operative
Closest Location: Coastal Vision · Orange, CA
Photo of Orange 1Photo of Orange 2Photo of Orange 3
2016First Recorded Clinical Trial
2 TrialsResearching Cataract
5 CompletedClinical Trials

Who is running the clinical trial?

Johnson & Johnson Surgical Vision, Inc.Lead Sponsor
27 Previous Clinical Trials
7,056 Total Patients Enrolled
23 Trials studying Cataract
6,452 Patients Enrolled for Cataract
Johnson & Johnson Surgical Vision, Inc. Clinical TrialStudy DirectorJohnson & Johnson Surgical Vision, Inc.
3 Previous Clinical Trials
3,220 Total Patients Enrolled
2 Trials studying Cataract
3,160 Patients Enrolled for Cataract

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are at least 22 years old.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.